Novo Nordisk
OrganizationHeard in 39 episodes across 14 shows since May 2026
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. It is a global leader in healthcare, specializing in the development and manufacture of diabetes and obesity medications, including insulin and semaglutide.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Novo Nordisk per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Jul 21 | 1.05‰ | 1 |
| Jul 31 | 1.78‰ | 2 |
| Aug 5 | 0.47‰ | 1 |
| Aug 12 | 0.04‰ | 1 |
| Aug 14 | 0.06‰ | 1 |
| Aug 20 | 0.17‰ | 4 |
| Aug 29 | 0.03‰ | 1 |
| Sep 1 | 0.06‰ | 1 |
| Sep 7 | 0.07‰ | 1 |
| Sep 8 | 0.35‰ | 9 |
| Sep 12 | 0.38‰ | 1 |
| Sep 13 | 0.41‰ | 1 |
| Sep 17 | 0.08‰ | 1 |
| Sep 18 | 0.11‰ | 1 |
| Sep 19 | 0.11‰ | 1 |
| Sep 21 | 0.19‰ | 4 |
| Sep 22 | 0.21‰ | 1 |
What experts have said about Novo Nordisk
9 statements · 3 positive · 6 negative
Novo Nordisk disappointed investors with its turnaround plans.
“Novo Nordisk. Disappointing investors here.”
Open the episode · Novo Slides; Accenture Up; Arhaus UpgradeListen at 2:22
Novo Nordisk quickly lost its GLP-1 market lead to Eli Lilly.
“it quickly lost its lead. to Eli Lilly.”
Open the episode · Novo Slides; Accenture Up; Arhaus UpgradeListen at 2:31
Loss of exclusivity will challenge Novo Nordisk
“this loss of exclusivity on some of those drugs is going to be a huge challenge for Novo Nordisk”
Open the episode · Novo Nordisk Drops, Puma Down, Trainline RisesListen at 1:12
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
39 episodes featuring Novo Nordisk, newest first
- Oct 4, 2026
Cornell case exposes gaps between campus, police and prosecutorsTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeOct 4, 2026 - Oct 4, 2026
Experts challenge silence around sexual assault allegationsTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeOct 4, 2026 - Oct 3, 2026
Shannon Beador turns sorority politics into a leadership case studyTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeOct 3, 2026 - Oct 3, 2026
Seven Nobel contenders test the limits of prize recognitionFrom First PrinciplesOct 3, 2026 - Oct 2, 2026
Anthropic’s IPO exposes AI’s costly investor dilemmaRich Habits PodcastOct 2, 2026 - Sep 22, 2026
Alibaba’s AI push meets rallies in apparel and biotechStock MoversSep 22, 2026